Praxis Precision Medicines, Inc. (PRAX) Technical Analysis & Indicators

Praxis Precision Medicines, Inc. (PRAX) — Price $273.99 (closing price, November 2, 2026) — Healthcare — Biotechnology — NASDAQ

Latest reported results:

Technical analysis of Praxis Precision Medicines, Inc. (PRAX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.

Praxis Precision Medicines, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating innovative treatments for central nervous system (CNS) conditions that stem from an imbalance in neuronal activity.

Price Performance

1 month-7.28%
3 months-14.17%
Year-to-date-7.04%
1 year+50.55%
3 years+1530.89%
5 years-17.79%

52-Week Range

52-week High$392.70
52-week Low$154.45
Avg Volume (90d)452K

Technical Indicators

SMA 50$299.25
SMA 200$314.72
Beta2.97
30-day Volatility (annualised)52.6%
Price vs SMA 50-8.4%
Price vs SMA 200-12.9%

Monthly Close (12 months)

MonthCloseChange
2025-12$294.74
2026-01$314.00+6.5%
2026-02$336.75+7.2%
2026-03$322.19-4.3%
2026-04$318.83-1.0%
2026-05$349.97+9.8%
2026-06$334.79-4.3%
2026-07$307.83-8.1%
2026-08$350.30+13.8%
2026-09$291.23-16.9%
2026-10$285.93-1.8%
2026-11$273.99-4.2%

Upcoming Earnings

DateEPS Est.Revenue Est.
2026-11-09$-3.54
2026-08-06$-3.67$1M
2026-05-07$-3.58
2026-02-19$-3.13
2025-11-05$-3.45
2025-08-04$-3.40
2025-05-02$-3.20

Price

Price$273.99 (closing price, November 2, 2026)
Market Cap$7.6B
ExchangeNASDAQ
CountryUS

Valuation Ratios

Price / Book5.95
Dividend Yield0.00%

Financial Health

Debt / Equity0.00
Current Ratio15.73
Piotroski F-Score2
Altman Z-Score64.44

Related companies: NBIX · AXSM · XENE · ACAD · DNLI · SUPN

Explore sector: Healthcare · Biotechnology

More sections of PRAX: Overview · Financials · Valuation · Statistics · Estimates · Ownership · News · Events

Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks